Literature DB >> 30591719

Cancer: Combating resistance to EGFR inhibitors.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID: 30591719     DOI: 10.1038/nrd.2018.232

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

Authors:  Khyati N Shah; Roma Bhatt; Julia Rotow; Julia Rohrberg; Victor Olivas; Victoria E Wang; Golzar Hemmati; Maria M Martins; Ashley Maynard; Jonathan Kuhn; Jacqueline Galeas; Hayley J Donnella; Swati Kaushik; Angel Ku; Sophie Dumont; Gregor Krings; Henry J Haringsma; Liliane Robillard; Andrew D Simmons; Thomas C Harding; Frank McCormick; Andrei Goga; Collin M Blakely; Trever G Bivona; Sourav Bandyopadhyay
Journal:  Nat Med       Date:  2018-11-26       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.